Immatics (IMTX) Cash from Investing Activities (2019 - 2025)

Immatics' (IMTX) quarterly Cash from Investing Activities came in at -$33.7 million in Q4 2025, up 33.55% year-on-year from -$25.2 million in Q4 2024, and down 123.48% quarter-over-quarter from $143.4 million in Q3 2025.

Immatics (IMTX) Cash from Investing Activities (2019 - 2025) Analysis & Trends

Immatics has disclosed Cash from Investing Activities across 7 years of filings, most recently posting -$33.7 million for Q4 2025.

  • Cash from Investing Activities for Q4 2025 came in at -$33.7 million, up 33.55% year-over-year; the trailing twelve-month figure through Dec 2025 was $231.7 million (up 240.78% YoY), and the FY2025 annual result was $231.4 million, up 242.08% from the prior year.
  • Cash from Investing Activities came in at -$33.7 million for Q4 2025 at Immatics, down from $143.4 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $143.4 million in Q3 2025 to a low of -$262.7 million in Q1 2024.
  • The 5-year median for Cash from Investing Activities is -$3.0 million (2023), against an average of -$8.7 million.
  • Peak annual rise in Cash from Investing Activities reached 510.15% in 2024, while the deepest fall reached 6481.11% in 2024.
  • Immatics' Cash from Investing Activities stood at -$2.1 million in 2021, then plunged by 4300.84% to -$92.0 million in 2022, then surged by 169.84% to $64.3 million in 2023, then plunged by 178.82% to -$50.7 million in 2024, then surged by 33.55% to -$33.7 million in 2025.
  • The last three Cash from Investing Activities figures came in at -$33.7 million (Q4 2025), $143.4 million (Q3 2025), and $72.7 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.89 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 638.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -431.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 579,519.10
10 Immatics 14.67 Bn 14.67 Bn - -33.66 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -33.66 Mn
Dec 31, 2025 -33.66 Mn
Sep 30, 2025 143.39 Mn
Sep 30, 2025 143.39 Mn
Jun 30, 2025 72.73 Mn
Jun 30, 2025 72.73 Mn
Mar 31, 2025 49.24 Mn
Mar 31, 2025 49.24 Mn
Dec 31, 2024 -50.66 Mn
Dec 31, 2024 -50.66 Mn
Sep 30, 2024 73.59 Mn
Sep 30, 2024 73.59 Mn
Jun 30, 2024 75.19 Mn
Jun 30, 2024 75.19 Mn
Mar 31, 2024 -262.70 Mn
Mar 31, 2024 -262.70 Mn
Dec 31, 2023 64.27 Mn
Dec 31, 2023 64.27 Mn
Sep 30, 2023 -76.82 Mn
Sep 30, 2023 -76.82 Mn